Dahl R - Search Results

1

Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD.

Murphy L, Rennard S, Donohue J, Molimard M, Dahl R, Beeh KM, Dederichs J, Fülle HJ, Higgins M, Young D. Murphy L, et al. Among authors: dahl r. Drugs. 2014 Sep;74(14):1635-57. doi: 10.1007/s40265-014-0284-7. Drugs. 2014. PMID: 25212789 Review.

2

The impact of treatment with indacaterol in patients with COPD: A post-hoc analysis according to GOLD 2011 categories A to D.

Kerstjens HA, Deslée G, Dahl R, Donohue JF, Young D, Lawrence D, Kornmann O. Kerstjens HA, et al. Among authors: dahl r. Pulm Pharmacol Ther. 2015 Jun;32:101-8. doi: 10.1016/j.pupt.2015.02.008. Epub 2015 Mar 3. Pulm Pharmacol Ther. 2015. PMID: 25743376 Free article.

3

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study.

Decramer ML, Chapman KR, Dahl R, Frith P, Devouassoux G, Fritscher C, Cameron R, Shoaib M, Lawrence D, Young D, McBryan D; INVIGORATE investigators. Decramer ML, et al. Among authors: dahl r. Lancet Respir Med. 2013 Sep;1(7):524-33. doi: 10.1016/S2213-2600(13)70158-9. Epub 2013 Aug 21. Lancet Respir Med. 2013. PMID: 24461613 Clinical Trial.

4

Efficacy of a new once-daily long-acting inhaled beta2-agonist indacaterol versus twice-daily formoterol in COPD.

Dahl R, Chung KF, Buhl R, Magnussen H, Nonikov V, Jack D, Bleasdale P, Owen R, Higgins M, Kramer B; INVOLVE (INdacaterol: Value in COPD: Longer Term Validation of Efficacy and Safety) Study Investigators. Dahl R, et al. Thorax. 2010 Jun;65(6):473-9. doi: 10.1136/thx.2009.125435. Thorax. 2010. PMID: 20522841 Clinical Trial.

5

Safety and tolerability of indacaterol in asthma: a randomized, placebo-controlled 28-day study.

Chuchalin AG, Tsoi AN, Richter K, Krug N, Dahl R, Luursema PB, Cameron R, Bao W, Higgins M, Woessner R, van As A. Chuchalin AG, et al. Among authors: dahl r. Respir Med. 2007 Oct;101(10):2065-75. doi: 10.1016/j.rmed.2007.06.002. Epub 2007 Jul 20. Respir Med. 2007. PMID: 17643277 Free article. Clinical Trial.

6

Pharmacodynamics and Pharmacokinetics Following Once-Daily and Twice-Daily Dosing of Tiotropium Respimat^® in Asthma Using Standardized Sample-Contamination Avoidance.

Beeh KM, Kirsten AM, Dusser D, Sharma A, Cornelissen P, Sigmund R, Moroni-Zentgraf P, Dahl R. Beeh KM, et al. Among authors: dahl r. J Aerosol Med Pulm Drug Deliv. 2016 Oct;29(5):406-415. doi: 10.1089/jamp.2015.1260. Epub 2016 Feb 9. J Aerosol Med Pulm Drug Deliv. 2016. PMID: 26859538 Free PMC article.

7

Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients.

Wedzicha JA, Dahl R, Buhl R, Schubert-Tennigkeit A, Chen H, D'Andrea P, Fogel R, Banerji D. Wedzicha JA, et al. Among authors: dahl r. Respir Med. 2014 Oct;108(10):1498-507. doi: 10.1016/j.rmed.2014.07.011. Epub 2014 Aug 4. Respir Med. 2014. PMID: 25135743 Free article. Clinical Trial.

8

Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study.

Dahl R, Jadayel D, Alagappan VK, Chen H, Banerji D. Dahl R, et al. Int J Chron Obstruct Pulmon Dis. 2013;8:501-8. doi: 10.2147/COPD.S49615. Epub 2013 Oct 17. Int J Chron Obstruct Pulmon Dis. 2013. PMID: 24159259 Free PMC article. Clinical Trial.

9

A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids.

Kerwin E, Pascoe S, Bailes Z, Nathan R, Bernstein D, Dahl R, von Maltzahn R, Robbins K, Fowler A, Lee L. Kerwin E, et al. Among authors: dahl r. Respir Res. 2020 Jun 12;21(1):148. doi: 10.1186/s12931-020-01400-5. Respir Res. 2020. PMID: 32532275 Free PMC article. Clinical Trial.

10

The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.

Anzueto A, Wise R, Calverley P, Dusser D, Tang W, Metzdorf N, Dahl R. Anzueto A, et al. Among authors: dahl r. Respir Res. 2015 Sep 15;16(1):107. doi: 10.1186/s12931-015-0269-4. Respir Res. 2015. PMID: 26369563 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,089 results

Search Page

Filters